COVid Test
Molecular salivary test COVid
COVid is the MC Biotech’s diagnostic response to the global health emergency of COVID-19.
COVid is a molecular diagnostic test allowing the identification of the RNA of the SARS-CoV-2 virus from saliva samples. The test uses patented isothermal amplification technology and was developed in collaboration with the Italian Institute of Technology, a center of excellence for Italian research.
Learn more about the COVid test: non-invasive, easy and fast
- Non-invasive sampling: the choice of saliva allows solving the problem of invasiveness of the nasopharyngeal swab and carrying out repeated and frequent analyses.
- Fast and all-in-one technology, that speeds up the analysis times allowing to increase the diagnostic capacity.
Thanks to the use of saliva, COVid represents a strategic solution for frequent screenings and for children and adolescents, offering the ideal test to ensure COVID-free schools and recreational environments.
Ease and speed of sample collection and testing make COVid a winning strategy for companies, sport professionals, tourism, and travels, allowing large-scale routine analysis.
MC Biotech offers two versions of the COVid saliva test: the high-throughput one for the standard lab instrumentation, and the point-of-care one for the MCBiotron integrated platform.
COVid is a CE-IVD certified diagnostic test, authorized by the Italian Ministry of Health. Patents: EP1275715; EP2253717; EP1327679; EP2031058.
COVid high-throughput
COVid point-of-care
POC COVid is also available in the nasal swab version